Spero Therapeutics is trading 5.6% higher at $1.32, possibly reflecting improved pre-market risk appetite, though confidence in that explanation is limited. - The stock is up from its September 24, 2026 close of $1.25. - No fresh company-specific announcement or clearly identified overnight catalyst surfaced in available coverage. - The Nasdaq Composite is up 0.68%, with major indices also higher.